On January 18, 2025, an expert team from the Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences (SIAT, CAS) visited Zhuhai Sailner Digital Medical Technology Co., Ltd. (Sailner Digital Medical). The two sides held in-depth exchanges and discussions on cooperation in the digital healthcare field.

In the morning, the head of Sailner Digital Medical’s Digital Medical Products Department briefed the SIAT experts in the company showroom on the Group’s overall development and application demonstrations.

In the subsequent meeting, the Sailner Digital Medical team highlighted to the visiting experts its independently developed full-color multi-material one-piece molding technology with proprietary core capabilities—including printing equipment, materials, and software—and also introduced the company’s business, products, and successful cases.

Yin Xinli, Vice General Manager for Digital Medical, introduced the current status, plans, and software talent needs of the AI modeling software under development, elaborated on how AI modeling software empowers clinical practice by improving treatment precision, shortening operative time, and raising surgical efficiency, and briefly shared technical bottlenecks and future trends in the medical digitalization industry.

Ruan Changshun, President of SIAT, introduced the team members and shared projects under research. Finally, both sides held in-depth discussions on digital medical applications, materials, talent development, research funding applications, and translation, laying a foundation for subsequent deeper cooperation.

After the meeting, the expert team toured Sailner Digital Medical’s printing workshop, observed the 3D-printed product manufacturing process up close, and highly praised Sailner Digital Medical’s printing technology, noting outstanding performance in technological innovation and application practice. They look forward to deeper cooperation across more fields to jointly advance the development and application of digital medical technologies. 

This exchange was an important step in cooperation between the two sides in digital healthcare. Through in-depth communication, they reached consensus on multiple fronts, providing a clear direction and a strong opportunity for follow-on collaboration. Going forward, the two sides will pursue broader cooperation in technology R&D and application promotion, jointly explore new models and pathways in digital healthcare, and contribute to progress in the medical industry.